Single-dose pharmacokinetics of the direct renin inhibitor aliskiren in healthy Chinese subjects.

被引:0
|
作者
Bartlett, M. [1 ]
Vaidyanathan, S. [2 ]
Karan, R. S. [2 ]
Hu, P. [3 ]
Howard, D. [4 ]
Yeh, C. M. [4 ]
Dieterich, H. A. [1 ]
Al-Fayoumi, S. [4 ]
Jarugula, V. [4 ]
Doles, W. P. [5 ]
机构
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Healthcare Private Ltd, Hyderabad, Andhra Pradesh, India
[3] Beijing Union Med Coll Hosp, Beijing, Peoples R China
[4] Nova Pharmaceut Corp, E Hanover, NJ USA
[5] Novartis Inst Biomed Res Inc, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S62 / S62
页数:1
相关论文
共 50 条
  • [41] The effects of ketoconazole and rifampin on the single-dose pharmacokinetics of crizotinib in healthy subjects
    Xu, Huiping
    O'Gorman, Melissa
    Tan, Weiwei
    Brega, Nicoletta
    Bello, Akintunde
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (12) : 1441 - 1449
  • [42] Effect of Rifampin on the Single-Dose Pharmacokinetics of Oral Cabotegravir in Healthy Subjects
    Ford, S. L.
    Sutton, K.
    Lou, Y.
    Zhang, Z.
    Tenorio, A.
    Trezza, C.
    Patel, P.
    Spreen, W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (10)
  • [43] Effects of age and sex on single-dose pharmacokinetics of tigecycline in healthy subjects
    Muralidharan, G
    Fruncillo, RJ
    Micalizzi, M
    Raible, DG
    Troy, SM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (04) : 1656 - 1659
  • [44] Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects
    Posvar, EL
    Radulovic, LL
    Cilla, DD
    Whitfield, LR
    Sedman, AJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (08): : 728 - 731
  • [45] Pharmacokinetics and bioequivalence of two oral formulations of canagliflozin after single-dose administration in healthy Chinese subjects
    Hu, Wei
    Yang, Yaru
    Zhang, Qian
    Yang, Yang
    Zhou, Renpeng
    Lu, Chao
    Liu, Zeyuan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (01) : 57 - 66
  • [46] Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Domperidone After Single-Dose Administration in Healthy Chinese Subjects
    Ye, Libing
    Shen, Minmin
    Chen, Yingrong
    Li, Xiaofeng
    Xu, Min
    Yao, Chong
    Yang, Shuixin
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (09): : 1084 - 1091
  • [47] THE EFFECTS OF MULTIPLE DOSES OF ROLOFYLLINE ON THE SINGLE DOSE PHARMACOKINETICS OF THEOPHYLLINE IN HEALTHY SUBJECTS.
    Dishy, V.
    Stroh, M.
    Hwang, E.
    Lazarus-Shipitofsky, N.
    Dittrich, H. C.
    Lai, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S12 - S12
  • [48] Single-dose pharmacokinetics, pharmacodynamics and safety of AZD0837, a novel oral direct thrombin inhibitor, in young healthy male subjects
    Johansson, S.
    Cullberg, M.
    Eriksson, U. G.
    Elg, M.
    Duner, K.
    Jensen, E.
    Wollbratt, M.
    Wahlander, K.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (04) : 258 - 267
  • [49] Single-dose pharmacokinetics and safety of saxagliptin in subjects with hepatic impairment compared with healthy subjects
    Patel, Chirag
    Castaneda, Lorna
    Frevert, Uli
    Li, Li
    Kornhauser, David M.
    Boulton, David W.
    DIABETES, 2008, 57 : A160 - A160
  • [50] THE EFFECTS OF MULTIPLE DOSES OF ROLOFYLLINE ON THE SINGLE DOSE PHARMACOKINETICS OF MIDAZOLAM IN HEALTHY SUBJECTS.
    Dishy, V.
    Stroh, M.
    Hwang, E.
    Lazarus-Shipitofsky, N.
    Dittrich, H. C.
    Lai, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S11 - S12